These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
44. Genotype-phenotype relationships of presenilin-1 mutations in Alzheimer's disease: an update. Larner AJ; Doran M J Alzheimers Dis; 2009; 17(2):259-65. PubMed ID: 19221408 [TBL] [Abstract][Full Text] [Related]
45. Tau is central in the genetic Alzheimer-frontotemporal dementia spectrum. Dermaut B; Kumar-Singh S; Rademakers R; Theuns J; Cruts M; Van Broeckhoven C Trends Genet; 2005 Dec; 21(12):664-72. PubMed ID: 16221505 [TBL] [Abstract][Full Text] [Related]
48. Mutational analysis in early-onset familial dementia in the Japanese population. The role of PSEN1 and MAPT R406W mutations. Ikeuchi T; Kaneko H; Miyashita A; Nozaki H; Kasuga K; Tsukie T; Tsuchiya M; Imamura T; Ishizu H; Aoki K; Ishikawa A; Onodera O; Kuwano R; Nishizawa M Dement Geriatr Cogn Disord; 2008; 26(1):43-9. PubMed ID: 18587238 [TBL] [Abstract][Full Text] [Related]
49. Genetic screening in early-onset Alzheimer's disease identified three novel presenilin mutations. Wong TH; Seelaar H; Melhem S; Rozemuller AJM; van Swieten JC Neurobiol Aging; 2020 Feb; 86():201.e9-201.e14. PubMed ID: 30797548 [TBL] [Abstract][Full Text] [Related]
50. C9ORF72 repeat expansions and other FTD gene mutations in a clinical AD patient series from Mayo Clinic. Wojtas A; Heggeli KA; Finch N; Baker M; Dejesus-Hernandez M; Younkin SG; Dickson DW; Graff-Radford NR; Rademakers R Am J Neurodegener Dis; 2012; 1(1):107-18. PubMed ID: 23383383 [TBL] [Abstract][Full Text] [Related]
52. Presenilin-1 (PSEN1) Mutations: Clinical Phenotypes beyond Alzheimer's Disease. Yang Y; Bagyinszky E; An SSA Int J Mol Sci; 2023 May; 24(9):. PubMed ID: 37176125 [TBL] [Abstract][Full Text] [Related]
53. PSEN1 L226F mutation in a patient with early-onset Alzheimer's disease in Korea. Bagyinszky E; Park SA; Kim HJ; Choi SH; An SS; Kim SY Clin Interv Aging; 2016; 11():1433-1440. PubMed ID: 27785004 [TBL] [Abstract][Full Text] [Related]
54. Atypical early-onset Alzheimer's disease caused by the Iranian APP mutation. Lindquist SG; Nielsen JE; Stokholm J; Schwartz M; Batbayli M; Ballegaard M; Erdal J; Krabbe K; Waldemar G J Neurol Sci; 2008 May; 268(1-2):124-30. PubMed ID: 18187157 [TBL] [Abstract][Full Text] [Related]
55. Genetic risk and transcriptional variability of amyloid precursor protein in Alzheimer's disease. Brouwers N; Sleegers K; Engelborghs S; Bogaerts V; Serneels S; Kamali K; Corsmit E; De Leenheir E; Martin JJ; De Deyn PP; Van Broeckhoven C; Theuns J Brain; 2006 Nov; 129(Pt 11):2984-91. PubMed ID: 16931535 [TBL] [Abstract][Full Text] [Related]
56. Linear patterns of Alzheimer's disease mutations along alpha-helices of presenilins as a tool for PS-1 model construction. Jozwiak K; Zekanowski C; Filipek S J Neurochem; 2006 Sep; 98(5):1560-72. PubMed ID: 16923167 [TBL] [Abstract][Full Text] [Related]
57. Increase in presenilin 1 (PS1) levels in senescence-accelerated mice (SAMP8) may indirectly impair memory by affecting amyloid precursor protein (APP) processing. Kumar VB; Franko M; Banks WA; Kasinadhuni P; Farr SA; Vyas K; Choudhuri V; Morley JE J Exp Biol; 2009 Feb; 212(Pt 4):494-8. PubMed ID: 19181896 [TBL] [Abstract][Full Text] [Related]
58. Mutations in presenilin 2 and its implications in Alzheimer's disease and other dementia-associated disorders. Cai Y; An SS; Kim S Clin Interv Aging; 2015; 10():1163-72. PubMed ID: 26203236 [TBL] [Abstract][Full Text] [Related]
59. Prevalence of pathogenic mutations in an Italian clinical series of patients with familial dementia. Signorini S; Ghidoni R; Barbiero L; Benussi L; Binetti G Curr Alzheimer Res; 2004 Aug; 1(3):215-8. PubMed ID: 15975068 [TBL] [Abstract][Full Text] [Related]